Lisata Therapeutics, Inc.

LSTA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0000320017

SEC filings (opens in a new tab)

No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Lisata Therapeutics, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022 All holders in Q3 2022

13F holders of LSTA: Q3 2022 compared with Q4 2022
Measure	Q3 2022	Q4 2022	Change
Holders	22	24	+2
Shares	470.7K	724.9K	+254.2K (+54.0%)
Value	$2.17M	$1.83M	−$344.4K (−15.8%)

New holders (3)

Institutions that held Lisata Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to LSTA in Q4 2022
Institution	Shares	Value	% of portfolio
BML Capital Management, LLC	243,839	$616.9K	0.59%
Citadel Advisors LLC	10,082	$25.1K	0.00%
Tower Research Capital LLC (TRC)	1,596	$4.00K	0.00%

Sold out (1)

Institutions that held Lisata Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of LSTA in Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Cutler Group LP	66	$0